TABLE 1.
Recommended FA dose and definition of NTD risk groups | |||||||
---|---|---|---|---|---|---|---|
Low risk | Intermediate/moderate risk | High risk | |||||
Organization | Year | Dose, μg | Definition | Dose, μg | Definition | Dose, μg | Definition |
US CDC (5) | 1991 | — | — | — | — | 4000 | Women who have had a pregnancy resulting in an infant or fetus with an NTD |
US Public Health Service (29) | 1992 | 400 | All women of childbearing age in the United States who are capable of becoming pregnant | — | — | — | — |
Society of Obstetricians and Gynaecologists of Canada (7, 30–32) | 1993 | 400 | Women of childbearing age and low NTD risk planning a pregnancy2 | 1000–4000 | No NTD history, but have T1D, epilepsy treatment, first-degree relative with NTD, FA antagonist use | 4000 | Previous pregnancy with NTD |
2003 | 400–1000 | Women of childbearing age and low NTD risk planning a pregnancy | 4000–5000 | No NTD history, but have T1D, epilepsy treatment, first-degree relative with NTD, FA antagonist use | 4000–5000 | Previous pregnancy with NTD | |
2007 | 400–1000 | No personal health risks, planned pregnancy, good compliance | 5000 | Epilepsy, T1D, obesity with BMI > 35 kg/m2, family history of NTD, high-risk ethnic group (e.g., Sikh); history of poor compliance with medications, variable diet, no consistent birth control, possible teratogenic substance use (alcohol, tobacco, recreational nonprescription drugs) | 5000 | Previous pregnancy with NTD or other potentially folate-responsive congenital anomaly | |
2015 | 400 | Women or male partners with no personal or family history of FA-sensitive birth defects | 1000–4000 | First or second family history of NTD, personal history of other folate-sensitive congenital anomalies, maternal diabetes, teratogenic medications, maternal GI malabsorption conditions | 4000 | Personal history of NTD or previous NTD pregnancy in either partner | |
Health Canada and the Public Health Agency of Canada (6, 33) | 1993 | — | As early as possible, women planning a pregnancy should consult physician about FA supplements | — | — | — | Previous NTD pregnancy, refer to physician |
1995–2018 | 4003 | All women who could become pregnant | — | Refer to health care provider | — | Refer to health care provider |
1FA, folic acid; GI, gastrointestinal; NTD, neural tube defect; T1D, type 1 diabetes.
2Women should consider a minimum of 400 μg FA or the adequate dietary equivalent according to Canada's Food Guide to Healthy Eating.
3As part of a multivitamin containing 400 μg FA.